Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia.

Blood - 15 May 1992

Baldini L, Cro L, Calori R, Nobili L, Silvestris I, Maiolo A T

Abstract excerpt

The expression of beta 1 (very late activation antigens, VLA 1-6) and beta 2 integrins (leukocyte adhesion molecules [Leu-CAM]) in cell suspensions from the peripheral blood of 70 patients with B-cell chronic lymphocytic leukemia (B-CLL), 15 patients with leukemic lymphocytic lymphoma of intermediate differentiation (IDL), as well as from the lymph nodes of 20 patients with low/intermediate-grade non-Hodgkin's...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to B-Lymphocytes
Share to Leukemia, Lymphocytic, Chronic, B-Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lymphoma, B-Cell

Share to Palatine Tonsil

Share to Phenotype

Share to Reference Values

Share to Spleen

Source

Identifiers

PMID: 1586717

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia.PMID 1586717Read ↗

Differential expression of cell adhesion molecules in B-zone small lymphocytic lymphoma and other well-differentiated lymphocytic disorders.Semantic proximity Read ↗

Adhesion molecule expression on B-cells from acute and chronic lymphoid leukemias.Semantic proximity Read ↗

Differential expression of the LFA-1 molecule on the human peripheral blood mononuclear cell subpopulations.Semantic proximity Read ↗

Adhesion molecules expression in CLL: Potential impact on clinical and hematological parameters.Semantic proximity Read ↗

Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders.Semantic proximity Read ↗

CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia.Semantic proximity Read ↗

Expression of the α1β1 integrin, VLA-1, marks a distinct subset of human CD4+ memory T cellsSemantic proximity Read ↗

Expression of an adhesion molecule and homing in B-cell chronic lymphocytic leukaemia: II. L-selectin expression mediated cell adhesion revealed by immobilized analogue carbohydrates in B-cell chronic lymphocytic leukaemia and monoclonal lymphocytosis of undetermined significance.Semantic proximity Read ↗

Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia.Semantic proximity Read ↗

Changes in adhesion molecule expression on lymphoblasts during acute lymphoblastic leukemia treatment.Semantic proximity Read ↗

Adhesion molecules in non-Hodgkin's lymphoma.Semantic proximity Read ↗

[Linear and adhesive phenotype of tumor lymphocytes and clinical course of chronic leucosis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.